Loading clinical trials...
Loading clinical trials...
The purpose of this study is to compare the efficacy, safety and tolerance of 2 different dose levels of oral NXL103 with oral comparator in the treatment of community acquired pneumonia in adults
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novexel Inc
NCT06494072 · Community Acquired Pneumonia in Children
NCT06986148 · Community Acquired Pneumonia (CAP), Community Acquired Pneumonia
NCT06755814 · Community Acquired Pneumonia (CAP)
NCT07472114 · Community Acquired Pneumonia (CAP)
NCT07425561 · Pneumonia, Pneumonia - Bacterial, and more
Clinica de Enfermedades Resp. "Miguel de Servet" SA
Santiago
Complejo Asistencial Barros Luco Trudeau
Santiago
Hospital de Urgencia Asistencia Publica
Santiago
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions